Literature DB >> 11123890

Identification of active-site residues of the pro-metastatic endoglycosidase heparanase.

M D Hulett1, J R Hornby, S J Ohms, J Zuegg, C Freeman, J E Gready, C R Parish.   

Abstract

Heparanase is a beta-D-endoglucuronidase that cleaves heparan sulfate (HS) and has been implicated in many important physiological and pathological processes, including tumor cell metastasis, angiogenesis, and leukocyte migration. We report herein the identification of active-site residues of human heparanase. Using PSI-BLAST and PHI-BLAST searches of sequence databases, similarities were identified between heparanase and members of several of the glycosyl hydrolase families (10, 39, and 51) from glycosyl hydrolase clan A (GH-A), including strong local identities to regions containing the critical active-site catalytic proton donor and nucleophile residues that are conserved in this clan of enzymes. Furthermore, secondary structure predictions suggested that heparanase is likely to contain an (alpha/beta)(8) TIM-barrel fold, which is common to the GH-A families. On the basis of sequence alignments with a number of glycosyl hydrolases from GH-A, Glu(225) and Glu(343) of human heparanase were identified as the likely proton donor and nucleophile residues, respectively. The substitution of these residues with alanine and the subsequent expression of the mutant heparanases in COS-7 cells demonstrated that the HS-degrading capacity of both was abolished. In contrast, the alanine substitution of two other glutamic acid residues (Glu(378) and Glu(396)), both predicted to be outside the active site, did not affect heparanase activity. These data suggest that heparanase is a member of the clan A glycosyl hydrolases and has a common catalytic mechanism that involves two conserved acidic residues, a putative proton donor at Glu(225) and a nucleophile at Glu(343).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123890     DOI: 10.1021/bi002080p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  45 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Functional and structural characterization of a heparanase.

Authors:  Lisa Bohlmann; Gregory D Tredwell; Xing Yu; Chih-Wei Chang; Thomas Haselhorst; Moritz Winger; Jeffrey C Dyason; Robin J Thomson; Joe Tiralongo; Ifor R Beacham; Helen Blanchard; Mark von Itzstein
Journal:  Nat Chem Biol       Date:  2015-11-02       Impact factor: 15.040

3.  Significance of heparanase in cancer and inflammation.

Authors:  Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin
Journal:  Cancer Microenviron       Date:  2011-08-03

4.  Structural and biochemical characterization of glycoside hydrolase family 79 β-glucuronidase from Acidobacterium capsulatum.

Authors:  Mari Michikawa; Hitomi Ichinose; Mitsuru Momma; Peter Biely; Seino Jongkees; Makoto Yoshida; Toshihisa Kotake; Yoichi Tsumuraya; Stephen G Withers; Zui Fujimoto; Satoshi Kaneko
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

5.  Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.

Authors:  Victoria Cohen-Kaplan; Ilana Doweck; Inna Naroditsky; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 6.  Involvement of heparanase in atherosclerosis and other vessel wall pathologies.

Authors:  Israel Vlodavsky; Miry Blich; Jin-Ping Li; Ralph D Sanderson; Neta Ilan
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

7.  Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.

Authors:  Anurag Purushothaman; Ligong Chen; Yang Yang; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

8.  Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.

Authors:  Menachem Bitan; Lola Weiss; Michael Zeira; Eyal Zcharia; Shimon Slavin; Arnon Nagler; Israel Vlodavsky
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

9.  Contribution of eIF-4E inhibition to the expression and activity of heparanase in human colon adenocarcinoma cell line: LS-174T.

Authors:  Yu-Jie Yang; Ya-Li Zhang; Xu Li; Han-Lei Dan; Zhuo-Sheng Lai; Ji-De Wang; Qun-Ying Wang; Hai-Hong Cui; Yong Sun; Ya-Dong Wang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion.

Authors:  Valentina Masola; Claudio Maran; Evelyne Tassone; Angelica Zin; Angelo Rosolen; Maurizio Onisto
Journal:  BMC Cancer       Date:  2009-08-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.